FDA-Cleared (IND #150758) COVID-19 Therapy

BREAKING NEWS: THE FREE FDA-Cleared Study You Can't Afford to Ignore!

Take The SURVEY To Find Out If You Qualify For This Breakthrough Study For African Americans...

BREAKING NEWS: THE FREE FDA-CLEARED STUDY YOU CAN'T AFFORD TO IGNORE!

Take The SURVEY To Find Out If You Qualify For The Breakthrough Study...

BE A DIFFERENCE MAKER FOR ALL!

Take The SURVEY To Find Out If You Qualify For The Breakthrough Study For African Americans...

The FIRST FDA-CLEARED STUDY Specifically HELPing AFRICAN AMERICANS WITH THE CORONAVIRUS

This first & only COVID-19 study was set in place to prevent the rapid progression of the virus, improve recovery and survival of African Americans, or anyone who is symptomatic.

Watch Dr. Harris And Dr. Bryan Discuss The Study

This is the first and only COVID-19 study specifically addressing the health disparities in African Americans, one of the most

affected, high-risk populations of the virus.

Plus, it’s FREE to join the study!

THE BREAKTHROUGH COVID-19 TREATMENT

NOviricid is the first oral Nitric Oxide (NO) generating drug to be clinically tested to treat African Americans diagnosed with COVID-19.

NOviricid is the first oral Nitric Oxide (NO) generating drug to be clinically tested to treat African Americans diagnosed with COVID-19.

Recent reports from the U.S. database compiled by CDC reports mortality from COVID-19 to have a racial disparity [2]. A disproportionate number of COVID-19 fatalities among African Americans has been observed.

Early data coming out of China revealed patients with underlying cardiovascular disease were more susceptible to infection, greater disease severity, and a ten times higher mortality.

  • Hypertension is highly prevalent in African Americans with an association with diminished nitric oxide (NO) levels [4]
  • Hypertension often leads to the development of a cardiomyopathy and heart failure [5]
  • Additionally, there are unique manifestations to the COVID-19 disease that make African Americans with low NO potentially at higher risk.

This current clinical trial aims to test the efficacy of a more potent nitric oxide lozenge (30 mg sodium nitrite) on patients diagnosed with COVID-19 infection to investigate if restoring nitric oxide can prevent the progression of the disease, reduced need for ventilation, and decreased death.

Nitric oxide drug therapy will address all of the underlying risk factors for African Americans with COVID and protect from the long term complications of COVID, including the risk of blood clots, embolism, heart attack, and stroke.

What Is Nitric Oxide? Watch 1-Min Video

What is Nitric Oxide?

Watch 1-Min Video Above

Recent reports from the U.S. database compiled by CDC reports mortality from COVID-19 to have a racial disparity [2]. A disproportionate number of COVID-19 fatalities among African Americans has been observed.

Early data coming out of China revealed patients with underlying cardiovascular disease were more susceptible to infection, greater disease severity, and a ten times higher mortality

  • Hypertension is highly prevalent in African Americans with an association with diminished nitric oxide (NO) levels [4]
  • Hypertension often leads to the development of a cardiomyopathy and heart failure [5]
  • Additionally, there are unique manifestations to the COVID-19 disease that make African Americans with low NO potentially at higher risk.

This current clinical trial aims to test the efficacy of a more potent nitric oxide lozenge (30 mg sodium nitrite) on patients diagnosed with COVID-19 infection to investigate if restoring nitric oxide can prevent the progression of the disease, reduced need for ventilation, and decreased death.

Nitric oxide drug therapy will address all of the underlying risk factors for African Americans with COVID and protect from the long term complications of COVID, including the risk of blood clots, embolism, heart attack, and stroke.

The NEW Approach To COVID...

To specifically address the health disparities in African Americans.

NOT another vaccine or anti-viral..

Dr. Richard Harris M.D., Pharm.D, MBA

Dr. Richard E Harris II is a board-certified internal medicine physician and pharmacist. Dr. Harris attended the University of Texas at Austin for pharmacy school then pursued medical education at the McGovern school of medicine in Houston. Dr. Harris completed his residency in Internal Medicine at UTMB in Galveston. Dr. Harris has a client-centric view focusing on building relationships and trust through a comprehensive lifestyle medicine system combined with genetic and micronutrient testing. In his spare time, he is an avid reader, weight lifter, video game enthusiast, and author. Dr. Harris also enjoys sports, traveling, philanthropy, church, and keto donuts.

Nathan S. Bryan, Ph.D.

Dr. Bryan earned his undergraduate Bachelor of Science degree in Biochemistry from the University of Texas at Austin and his doctoral degree from Louisiana State University School of Medicine in Shreveport where he was the recipient of the Dean’s Award for Excellence in Research. He pursued his post-doctoral training as a Kirschstein Fellow at Boston University School of Medicine in the Whitaker Cardiovascular Institute. After a two-year post-doctoral fellowship, in 2006 Dr. Bryan was recruited to join faculty at the University of Texas Health Science Center at Houston by Ferid Murad, M.D., Ph.D., 1998 Nobel Laureate in Medicine or Physiology. Dr. Bryan has made many seminal discoveries in the nitric oxide field that has resulted in over a dozen issued US and International patents. He is also a successful entrepreneur who has successfully commercialized his nitric oxide technology. Dr. Bryan has published a number of highly cited papers and authored or edited 5 books. He is an international leader in molecular medicine and nitric oxide biochemistry.

GETTING INVOLVED IN 3 EASY STEPS

1. Take The Survey

2. Entry Visit

3. Your Treatment

This Is a limited STUDY

You're not just another number, but a difference maker to the African American community.

This will impact the future of COVID patients around the world through your help.

840 Patients ONLY

Monitored for 30 Days

$100 CASH Payment

BECOME THE CHANGE In ImpactING THE FUTURE Health of African Americans

Here's What To Expect...

Here's What To Expect...

High Blood Pressure

COPD

Heart Failure

Kidney Disease

Diabetes

Smoking

Have One Of

The Top Health Disparities?

High Blood Pressure

COPD

Heart Failure

Kidney Disease

Diabetes

Smoking

This Is a limited STUDY

You're not just another number, but a difference maker to the African American community.

This will impact the future of COVID patients around the world through your help.

840 Patients ONLY

Monitored for 30 Days

$100 CASH Payment

This Is NOT A "Typical Study" Approach

This study is to specifically address the health disparities in people of color

one of the most affected, high-risk populations of the virus.

BE THE CHANGE TODAY!

This is the first and only COVID-19 study specifically addressing the health disparities in people of color

one of the most affected, high-risk populations of the virus.

Privacy Policy   |   Terms & Conditions

© Copyright 2020 Nitric Oxide innovations LLC - All rights reserved